AJAX Search

search:
joomla slideshow with caption

Representing the PRECLINICAL Portfolio of Mediso in North America

Mediso has a long history in the design, and manufacturing of high-end clinical and life science multi-modality in vivo molecular imaging systems. After 15 years of providing transformative clinical systems, Mediso preclinical systems were introduced in 2006 to address the need for more powerful and quantifiable in vivo imaging for research.

Mediso USA was founded to support all North American preclinical business, service, applications, and training. The flagship of the Mediso preclinical line, nanoScan Family, offers a state-of-the-art platform for small animal PET/SPECT/CT/MR imaging.

The ultimate in preclinical versatility and robust high-end imaging subsystems are based on a common hardware and software platform. Highlighting the versatility of the nanoScan family are the integrated bi-mode combinations of PET/CT, PET/MRI(3T), PET/MRI(1T), SPECT/CT, SPECT/MRI(1T) and the exclusive tri-mode SPECT/CT/PET. Whether your institution is adding a standalone nanoScan modality, precision integrated bi-mode or tri-mode system your investment is secure with a clear modality upgrade path and access to the latest developments for current and future research applications.

Performance is enhanced by efficient workflow. All nanoScan systems include the MultiCell small-animal handling systemsensuring efficient animal preparation, consistent anesthesia delivery, temperature control, and physiology monitoring. Acquisition, reconstruction, and analysis are streamlined by the Mediso-developed operators console consisting of the latest hardware, processors, and intuitive yet powerful software solutions:

PRESS RELEASES

Tulane National Primate Research Center receives the 100th Mediso preclinical PET system with installation of the MultiScan Large FOV Extreme Resolution (LFER150) PET/CT

Covington, LA and Boston, MA, October 2, 2018 /PRNewswire/  With the successful installation of the 100th Mediso multi-modality preclinical PET system, the Tulane National Primate Research Center (TNPRC), division of the Tulane University, has become the fourth site in North America to install the MultiScan LFER150 PET/CT preclinical imager.

Huntsman Cancer Institute becomes the first US installation of the nanoScan 3 Tesla PET/MRI

Salt Lake City, UT and Boston, MA, October 2, 2018 /PRNewswire/  The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake City, UT, has become the first site in the US to install the nanoScan PET/MRI 3T preclinical in vivo imaging system. This is the 10th installation of the nanoScan MRI 3T worldwide.

Mediso USA Reaches Milestone With 10th Site of Preclinical nanoScan Imaging Systems

Boston, MA, September 28, 2015 /PRNewswire/  Mediso USA is proud to announce the tenth site of integrated preclinical multimodality imagers of the nanoScan Family in North America, at the preeminent Cold Spring Harbor Laboratory (CSHL).

Huntsman Cancer Institute Becomes the First Mediso Preclinical Imaging Center of Excellence in North America

Salt Lake City, Utah and Boston, MA, September 21, 2015 /PRNewswire/ The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI), part of the University of Utah Health Care system in Salt Lake City, UT, has become the first site in North America to be designated as a Center of Excellence for Preclinical Imaging by Mediso Ltd. and its affiliate company Mediso USA.

Mediso USA Reaches Milestone With 10th Site of Preclinical nanoScan Imaging Systems

BOSTON, Massachusetts, September 28, 2015 /PRNewswire/

nanoScan PET/CT preclinical in vivo imagerMediso USA is proud to announce the tenth site of integrated preclinical multimodality imagers of the nanoScan Family in North America, at the preeminent Cold Spring Harbor Laboratory (CSHL). The nanoScan systems are developed and manufactured by Mediso Ltd., Hungary. Illes Muller, managing partner of Mediso USA commented: "We started our operations two years ago serving and supporting the professional and academic users in North America. The installation of a nanoScan PET(122S)/CT at CSHL brings a very important milestone for us. Six out of our ten nanoScan sites has a preclinical PET, either combined with CT or MRI".

The constant technological innovation makes the Mediso nanoScan family the first-line choice for small animal imaging. The PET(122S) subsystem is the improved version of the 16 cm wide bore preclinical PET system. The PET ring is the largest among currently available preclinical PET/CT imagers. The new acquisition electronics delivers increased count-rate tolerance and improved time resolution. The proprietary Tera-Tomo 3D PET reconstruction algorithm results in a uniform imaging resolution of ≤0.8mm even at 3cm off the radial center. Combined with high 8% sensitivity the PET technology enables the detection of femtomolar quantities of proteins per milligram of tissue with high resolution.

Scott Lyons, Research Assistant Professor at CSHL stated: "Cold Spring Harbor Laboratory is pursuing new ways to treat cancer and imaging technology helps our researchers visualize the effects of new cancer therapies dynamically over time. We look forward to deploying the new nanoScan PET/CT system as one of the tools for our research."

About Cold Spring Harbor Laboratory 

Celebrating its 125th anniversary in 2015, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory is more than 600 researchers and technicians strong. The Meetings & Courses Program hosts more than 12,000 scientists from around the world each year on its campuses in Long Island and in Suzhou, China. The Laboratory's education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers. For more information, visit http://www.cshl.edu

About Mediso USA 

Mediso USA distributes the preclinical imaging portfolio of Mediso Ltd. in US and Canada providing sales, application and technical support.